SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

TSX Growth Companies With High Insider Ownership In October 2025

The Best Discounted Stocks on the TSX to Snap Up Now

S&P/TSX soars, closing more than 500 points higher while U.S. markets end mixed

Wall Street ends mixed but TSX sharply higher in catch-up rally

S&P/TSX composite up more than 400 points while U.S. stock markets move lower